# The Human Medicines (Amendment) (Modular Manufacture and Point of Care) Regulations 2025, Regulation 28: Amendment of regulation 202A


After regulation 202A(2)(c) (licensing authority power in relation to medicinal products subject to additional monitoring) insert—
“(d) any MM medicinal product;
(e) any POC medicinal product.”.

---
Source: https://www.legislation.gov.uk/uksi/2025/87/regulation/28 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-modular-manufacture-and-point-of-care-regulations-2025/regulation-28
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

